55 Whitney Avenue, New Haven, CT

Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities

Protein antibody-based multiplexing provides

characterization of the most influential cell subsets based on their functional phenotype.

Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations

FOLLOW US

Novel Characterization of Cancer & Inflammatory Activity